z-logo
open-access-imgOpen Access
Prevalence of hypothyroidism in type 2 diabetic female Kurdish subjects
Author(s) -
SarheedJabar Muhammed,
DashtiHabbas Albustani
Publication year - 2018
Publication title -
medical journal of babylon
Language(s) - English
Resource type - Journals
eISSN - 2312-6760
pISSN - 1812-156X
DOI - 10.4103/mjbl.mjbl_99_18
Subject(s) - medicine , type 2 diabetes , endocrinology , diabetes mellitus
Background: The incidence of thyroid disorders is more prevalent in type 1 diabetes compared to type 2 diabetes, due to associated autoimmune disorders. Physiological and biochemical interconnection between type 1 diabetes mellitus and autoimmune thyroid disease is now stimulating subject of study. Objectives: The objective was to assess the prevalence of thyroid dysfunction among type 2 diabetic Kurdish females and to explore the correlation between metabolic syndrome components and autoimmune thyroid abnormality. Materials and Methods: The study included 60 type 2 diabetic Kurdish females and 30 sex- and age-matched controls. All patients in the study were exposed to anthropometric characteristics, including HbA1c, lipid profile, serum uric acid, thyroid-stimulating hormone (TSH), free triiodothyronine, free thyroxine, anti-thyroid peroxidase (TPO), and anti-thyroglobulin (anti-Tg). Results: Primary hypothyroidism was found in 24 (40%) diabetic patients (5.67 ± 3.35 μIU/mL) versus three (10%) controls (1.76 ± 1.19 μIU/mL) (P < 0.001). Anti-TPO was found in 66.7% (367.21 ± 234.53) of diabetic patients versus 10% (31.78 ± 32.14) of controls (P > 0.001). Anti-Tg was found in 60% (499.98 ± 358.14) of diabetic patients versus 0 (53.27 ± 36.23) controls (P > 0.001). A significant positive relationship was estimated between both TPO antibodies and Tg antibodies and TSH (P = 0.05 and P = 0.001, respectively) in diabetic patients. Conclusion: Autoimmune thyroid disorder is more prevalent in Kurdish women with type 2 diabetes than nondiabetic women, and thus points to a role of autoimmunity in the pathogenesis of type 2 diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom